
iNCOVACC is world’s first intranasal COVID-19 vaccine to receive approval for the primary 2-dose schedule, and as a heterologous booster…
Economic Survey 2023: The document tabled in the Parliament on Tuesday said, “Labour markets have recovered beyond pre-Covid levels, in…
Economic Survey 2023: India’s residential market has witnessed recovery this fiscal on pent-up demand with increase in housing sales despite…
Ines Blal, executive dean and MD of EHL Hospitality Business School, Lausanne, talks about the hospitality sector and the institution’s…
The study comes as an advisory panel for the Food and Drug Administration is due to meet Thursday, Jan. 26,…
The coronavirus keeps evolving, and in so doing it evades our immune defenses. But does the entire coronavirus evolve, or…
A vulnerable population, unvaccinated elders, ineffective vaccines and a poor health care system will ensure that the long-time relationship between…
The committee is expected to announce its decision on January 30.
According to GlobalData’s Pharma Intelligence Center,13 homegrown vaccines have been approved for use against COVID-19 in China.
If a person has taken a third dose of the anti-COVID-19 vaccine, it means his T-cell immune response has been…
The company also claimed that this is different from many other tests in the market that use RT-PCR signal drop-out…
This means Americans would no longer have to keep track of how many shots they’ve received or how many months…
Plant pathogens usually do not infect humans directly, and the harm is generally in the form of food insecurity.
Covovax is manufactured through technology transfer from Novavax.
“It is clarified that the news report is ill-informed and provides erroneous information,” the ministry said, referring to the report.
The Health ministry said 220.17 crore doses of COVID-19 vaccine have been administered under the nationwide vaccination drive so far.
The government had, in April 2021, first exempted Covid-19 vaccines from 10 per cent customs duty. The exemption was extended…
According to the double-blind, placebo-controlled clinical research findings, ArtemiC may minimize the severity of symptoms of COVID-19.